
|Articles|December 9, 2022
Inside Bioprocessing: Microbial bioproduction
Author(s)Thermo Fisher Scientific
The animal origin-free (AOF) trend in bioprocessing has taken a while to reach microbial bioproduction. In this podcast, we explore the reasons behind this and delve into how AOF products are impacting the future of biopharmaceutical manufacturing. We also discuss the first chemically defined microbial medium—the Gibco™ Bacto™ CD Supreme Fermentation Production Medium (FPM). Hydrolysate-free and AOF, this dry powder medium was specially designed to support high-cell-density cultures of E. Coli. Listen to bioprocessing experts and discover more.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Jubilant Biosys Announces New Facility in India
2
Medable Presents AI Agent for Automating Trial Master File Processes at JP Morgan Healthcare Conference
3
Gene Therapy, Rare Diseases, and Transfer RNA
4
Personalized Medicine Vs. Precision Medicine
5